‘Highly Probable’ Military Developed COVID, Leaked From Lab

March 29, 2021

http://  Approx. 12 Min.

March 21, 2021

The former lead investigator who spearheaded a taskforce for the US government into the origins of COVID-19 has declared the virus may have been the result of work done for a biological weapons program in Wuhan.
 
David Asher – a now senior fellow at the Hudson Institute – spoke to Sky News about investigations into the origins of COVID-19 and suspicions as to who may have been first infected with the virus in Wuhan. He spoke of work undertaken at the Wuhan Institute of Virology as well as the theory it may have developed SARS-COV-2 while working on a potential coronavirus vaccine.
 
The possible vaccine was potentially being developed as an antidote to a bioweapen, he said.
 
“Whether they were developing this vaccine, if it exists, as an antidote … hard to know,” he told Sky News host Sharri Markson. “There’s going to be the need for a huge global investigation, well beyond the WHO”. He said events and information have arisen which “made us feel the Wuhan Institute was highly probably the source of the COVID epidemic”.
 

STORY AT-A-GLANCE 

  • According to David Asher, former lead investigator for the U.S. State Department’s task force that looked into the origins of COVID-19, the data “made us feel the Wuhan Institute was highly probably the source of the COVID pandemic”
  • Asher also admits there is evidence in the genetic sequence of SARS-CoV-2 suggesting it’s been synthetically altered
  • An assessment report by the U.S. Defense Intelligence Agency states SARS-CoV-2 was likely an accidental release from an infectious diseases laboratory. Intentional release was ruled out
  • The Chinese tried to remove viral sequencing data from a European database. The sequences included adenovirus, a vaccine vector, which could indicate that SARS-CoV-2 is part of a vaccine program. Such a vaccine would likely be the antidote to a biological weapon
  • There’s evidence the Wuhan Institute of Virology worked on classified military programs, and since the NIH has funded gain-of-function research on coronaviruses at the WIV, this could mean the U.S. funded research that ended up being used in a Chinese military bioweapons program Source
Former CDC Director, Dr. Redfield also recently announced COVID was in Wuhan as early as September or October 2019.

But WHO states state it’s extremely unlikely COVID escaped from a lab despite pushback from scientists.

Jamie Metzl, former National Security Council official in the Clinton administration and member of a WHO advisory committee on genetic engineering, blamed the Chinese government for failing to cooperate with the WHO investigative team.

Metzl told 60 Minutes that even though there have been accidental lab leaks of viruses in China in the past that have infected people and killed at least one, “no one on the WHO team was trained in how to formally investigate a lab leak.”

Metzl is part of an international group that, on March 4, released an open letter calling for a full and unrestricted international forensic investigation into the origins of the pandemic. He told 60 Minutes that the lab leak theory is plausible and deserves a full investigation. He said that the Wuhan Institute of Virology’s (WIV) own lab reports show that it sent field researchers to the bat caves and that they brought back samples with coronaviruses:

“ … we do know that there were nine viruses at least that were brought back. And it’s extremely possible that among these viruses is a virus that’s much more closely related to the SARS-CoV-2 virus. And when I put all those pieces together, I said, ‘Hey, wait a second, this is a real possibility. We need to be exploring it.’”

Matt Pottinger, former Trump administration deputy national security adviser, also told 60 Minutes he believes China withheld information from the WHO team, including that the Wuhan lab director “published studies about manipulating bat coronaviruses in a way that could make them more infectious to humans, and there were reports of lax safety standards at the lab.”  Source

For more:

Category:

Viruses

Comments Off on ‘Highly Probable’ Military Developed COVID, Leaked From Lab

Human Trials Begin for Shot Against Lyme Disease

http://  Approx. 3 Min.

Human Trials Begin For Shot Against Lyme Diease

March 23, 2021

Lyme PrEP still uses OspA, the outer surface protein connected to Lyme-like symptoms caused by the previous Lymerix vaccine.

Excerpts:

Safety concerns began to emerge soon after people began getting LYMErix. Some recipients began to report joint pain and other effects that they attributed to the vaccine. Within a year of the vaccine’s approval, a class action lawsuit was filed against SmithKline Beecham on behalf of 121 people. Although the suit was eventually settled — it provided no compensation to the plaintiffs — publicity about it dampened interest in the vaccine.

Meanwhile, growing distrust of vaccines may have compounded LYMErix’s struggles.

But there is another possible point of contention: VLA15 and Lyme PrEP both target the same protein on Borrelia bacteria that LYMErix did — outer surface protein A (OspA).

The approach used to target OspA in LYMErix was linked to concerns that arose about potential side effects. While studies have not confirmed the connection, VLA15 uses a slightly modified vaccine approach and Lyme PrEP delivers a single antibody directly — both of which could circumvent the purported issue. But Telford said some people might still take issue with a vaccine that targets OspA.

“I anticipate Valneva is going to have a problem with activists,” he said, noting that he had informally spoken with some community groups. “The broad statement was ‘No OspA vaccine, no how.’”

Klempner, similar to other Lyme Cabal players has a history with biological weapons as both Director and investigator of a bioweapons lab.  He’s been accused of research fraud, and single-handedly has convinced mainstream medicine that extended treatment doesn’t help Lyme/MSIDS patients. The “Klempner” Report has ruled Lyme-land for over 20 years.

Further, I’m with Lyme advocate Carl Tuttle in that we don’t want a vaccine until the issue of chronic/persistent infection is acknowledged. As you can see from this article, there are those who still believe what we are suffering from is a “scam that should be condemned”.

Excerpt:

The Lyme disease controversy keeps on getting bigger, with an hypothetical presentation of “chronic Lyme disease” that some believe to be responsible for late subjective symptoms experienced by patients who are supposedly victims of this chronic infection despite negative examination results and unrelated clinical signs.

This irrational diatribe has been picked up by the media and orchestrated by sectarian supporters of such syndrome – i.e., off-the-rails physicians, associations proclaiming to “defend” the patient’s interests, and even political figures – and has grown into an absurd and troubling polemic. Untruths told by Lyme pseudo-specialists (i.e., the Lyme doctors) and assertions made by people convinced to have chronic Lyme disease are indeed picked up by the media – too eager to disseminate fake news and happy to see the medical authorities flouted – and work to the disadvantage of patients. Patients are fooled, taken advantage of, betrayed, and even encouraged to physically threaten physicians contesting the existence of such syndrome!

Tick-borne illness has been ruled by a Cabal doing pseudoscience, just as COVID has.

In fact, for those paying attention, there are many similarities between how Lyme/MSIDS & COVID have been handled.

For more:

Category:

Activism, Lyme, Lyme Vaccine, vaccines

Comments Off on Human Trials Begin for Shot Against Lyme Disease

Pilot Study Finds Evidence of Bartonella in Schizophrenia Patients

https://news.ncsu.edu/2021/03/pilot-study-bartonella-schizophrenia-patients/

Pilot Study Finds Evidence of Bartonella Infection in Schizophrenia Patients

March 23, 2021
NC State gateway at sunset
FOR IMMEDIATE RELEASE
Tracey Peake

A pilot study from North Carolina State University and the University of North Carolina at Chapel Hill has found evidence of Bartonella infection in the blood of people with schizophrenia and schizoaffective disorder.

“Researchers have been looking at the connection between bacterial infection and neuropsychiatric disease for some time,” says Dr. Erin Lashnits, a former veterinary internist at NC State, current faculty member at the University of Wisconsin and first author of the study.

“Specifically, there has been research suggesting that cat ownership is associated with schizophrenia due to the zoonotic parasite Toxoplasma gondii, but to date there has been no conclusive evidence in support of a causative role for this parasite. So we decided to look at another cat-associated infectious agent, Bartonella, to see if there could be a connection.”

Bartonella are bacteria historically associated with cat-scratch disease, which until recently was thought to be solely a short-lived (or self-limiting) infection. Cats can become infected with Bartonella via exposure to fleas and potentially ticks, which are natural vectors of the bacteria. The cat is a host for at least three of the 40 known Bartonella species: Bartonella henselae, Bartonella clarridgeiae and Bartonella koehlerae.

“While there is emerging understanding of neuropsychiatric illnesses such as schizophrenia as disorders of brain networks, the question about the actual causes remains unanswered,” says corresponding author Flavio Frohlich, associate professor of psychiatry at the UNC School of Medicine. “It was an exciting opportunity for us in the UNC Department of Psychiatry to team up with the leading experts on Bartonella to pursue this innovative idea of a potential link to schizophrenia. To our knowledge, this is the very first work that examines a potential role of Bartonella in schizophrenia.”

The research team enrolled a group of 17 people with stable, medically managed schizophrenia or schizoaffective disorder, and a control group of 13 healthy adults, to test for evidence of Bartonella infection.

All participants filled out questionnaires on severity of symptoms and potential Bartonella exposure. Blood samples were taken from participants twice in a one-week period. The samples were cultured in a growth medium, and both cultured and whole blood samples underwent qPCR and droplet digital, or ddPCR testing, at seven-, 14- and 21-day intervals, to look for evidence of Bartonella organism-specific DNA. Blood samples were also tested for Bartonella species-specific antibodies.

Of the 17 patients with schizophrenia, 12 had Bartonella DNA in their blood, as compared to only one of 13 in the control group. According to the questionnaires, both patients and controls reported similar pet ownership and flea exposures.

“Bartonella ddPCR, a very new diagnostic technology, provides a more sensitive molecular test than we’ve previously had access to,” says Dr. Ed Breitschwerdt, Melanie S. Steele Distinguished Professor of Internal Medicine at NC State and study coauthor. “If we had not used ddPCR to test this cohort of individuals, we would not have found Bartonella DNA in any of the participants, either case or control.”

“It is important to remember that our study was by design not able to demonstrate a causal link between Bartonella infection and schizophrenia,” Frohlich says. “However, we believe this initial observational study strongly supports the need for follow-up research.”

The researchers plan to proceed with a larger study to see whether their preliminary results are borne out.

“Many of these patients have been undergoing care for years,” Breitschwerdt says. “What we’re starting to see is a pattern – Bartonella can persist for a long time. And for the subset of people who can’t eliminate the infection, the bacteria can cause chronic or progressive illness.”

The research appears in Vector Borne and Zoonotic Diseases and was supported in part by the National Institutes of Health (grants UL1TR002489 and T32OD011130). Ricardo Maggi and Julie Bradley of NC State, as well as L. Fredrik Jarskog of UNC-Chapel Hill, contributed to the work.

_________________________

Note to editors: The abstract of the paper follows.

“Schizophrenia and Bartonella spp. infection: a pilot case-control study”

DOI: 10.1089/vbz.2020.2729

Authors: Erin Lashnits, Ed Breitschwerdt, Ricardo Maggi, Julie Bradley, North Carolina State Univerity; L. Fredrik Jarskog, Flavio Frolich, University of North Carolina at Chapel Hill
Published: March 15, 2021 in Vector-Borne and Zoonotic Diseases

Abstract:
Recently, infections with emerging zoonotic bacteria of the genus Bartonella have been reported in association with a range of central nervous system (CNS) symptoms. Currently, it remains unknown if Bartonella spp. infection is associated with symptoms of schizophrenia/schizoaffective disorder (SCZ/SAD). The objective of this study was to determine if there is an association between Bartonella species infection and SCZ/SAD. A secondary objective was to determine if SCZ/SAD symptoms were more severe among participants with documented Bartonella spp. infection. Using a case–control study design, 17 cases and 13 controls were evaluated with a series of clinical and cognitive assessments. Blood samples were collected and tested for Bartonella spp. infection using serological, microbiological, and molecular techniques. People with SCZ/SAD were more likely than healthy volunteers to have Bartonella spp. DNA in their bloodstream, with 11 of 17 cases (65%) positive by Bartonella spp. droplet digital PCR (ddPCR). In comparison, only one healthy volunteer was Bartonella spp. ddPCR positive (8%, p = 0.0024). Based on serology, Bartonella spp. exposure was common among people with SCZ/SAD (12 of 17) as well as among healthy volunteers (12 of 13), with no significant difference between the groups ( p = 0.196). Within the case group of people with SCZ/SAD, there was no significant difference in SCZ/SAD severity scores between people with and without ddPCR evidence of Bartonella spp. infection. This pilot study provides preliminary evidence in support of future investigations that should examine a potential contribution of Bartonella spp. infection to SCZ/SAD.

________________________

For more:

Category:

Bartonella, Psychological Aspects, research

Comments Off on Pilot Study Finds Evidence of Bartonella in Schizophrenia Patients

Study of a Potential Test for Persistent Lyme Disease

https://flightpath.bio

FLIGHTPATH BIOSCIENCES’

Study of a Potential Test for Persistent Lyme Disease

Thanks to the enthusiastic response from the Lyme community, this study has met its current enrollment goal. Therefore, Flightpath Biosciences’ Study of a Potential Test for Persistent Lyme Disease will not be accepting any more applications at this time.

We’ll keep you posted as the project proceeds or if we reopen the study for further enrollment.

For questions related to this study, please contact: FlightpathLymeStudy@gmail.com

https://news.northeastern.edu/2020/09/29/intestinal-bacteria-could-give-doctors-an-objective-test-for-chronic-lyme-disease

Excerpt:

Fatigue, muscles aches, brain fog—are these symptoms of chronic Lyme disease, or merely side effects of the daily grind of human existence? It’s hard to tell. 

Chronic Lyme disease, also known as post-treatment Lyme disease syndrome or PTLDS, is incredibly hard to diagnose because symptoms vary greatly, and there is currently no biological test to detect the disease.

Now, Kim Lewis, University Distinguished Professor of biology and director of the Antimicrobial Discovery Center at Northeastern, has proposed a new way to objectively diagnose this elusive disease by analyzing the microbes in a patient’s gut. 

(Go to link for article)

_______________________

**Comment**

Lewis states there are about 800,000 people in America living with PTLDS.  I have written before about this confusing moniker that it means different things to different people.  For instance, microbiologist Holly Ahern states there are two groups of patients: those diagnosed and treated early and those diagnosed and treated late.  The PTLDS label only concerns the first group and only represents about 10-20% of people going on with persistent symptoms.  These low percentages are typically what researchers are referring to.  The label leaves out a much larger group (30-40%) that is diagnosed and treated late.  

This second group represents nearly all the patients I work with that never gets addressed by research because their cases are sticky, hard to define, and by nature don’t fit well into a research study design.

According to Lewis, people with PTLDS have an abundance of a type of bacteria called Blautia and a suppression of a type of bacteria called Bacteroides (which explains why Lyme/MSIDS patients suffer with inflammation, digestion, improper immune responses, depression and anxiety).

Unfortunately, this bacterial disregulation is also seen in many other diseases.

Flightpath is also working on making an oral form of the antibiotic azlollicin available, which has demonstrated in vivo efficacy in mice by significantly inhibiting the growth of drug-tolerant Borrelia burgdorferi (Bb) bacteria better than doxycycline (the standard of care), and reducing inflammation.

 

Category:

Gut Health, Inflammation, Lyme, research, Testing

Comments Off on Study of a Potential Test for Persistent Lyme Disease

Bill Gates’ U Washington Lackies Publish New Paper Claiming HCQ Doesn’t Work. Let Me Count the Ways They Have Fixed The Result

March 26, 2021

http://anthraxvaccine.blogspot.com/2021/03/bill-gates-u-washington-lackies-publish.html

By Meryl Nass, M.D.

Thursday, March 4, 2021

Bill Gates’ U Washington lackies publish a new paper claiming HCQ doesn’t work. Let me count the ways they may have fixed the result

 1.  Bill Gates has poured lots of money into the University of Washington and its Global Health department and its Institute for Health Metrics and Evaluation (IHME).  Global Health and IHME share a new building provided them by BMGF, away from the campus but close to BMGF headquarters. Four years ago, BMGF gave them $489 million dollars, after founding the Global Health department ten years earlier. And why not?  He gets to control the world’s public health narratives with that money. And, apparently, much of the University of Washington as well:

“Through a generous gift and endowment from the Bill & Melinda Gates Foundation, and complementary Washington State resources, the UW Department of Global Health was established in 2007, bridging the schools of Medicine and Public Health, with a mandate to harness the expertise and interdisciplinary power of all 16 UW schools and colleges.” 

The Merriam Webster dictionary says a mandate is:

1. : an authoritative command
especially : a formal order from a superior court or official to an inferior one
2. : an authorization to act given to a representative 

You might want to read more about the IHME’s frauds and its close relationship to Bill Gates.  Journalist Tim Schwab did a wonderful expose on the IHME in December, inThe Nation. Its subtile is:

Thanks to the Microsoft founder’s support, the IHME can make its own rules about how to track global health. That’s a problem.

(See link for article)

_____________________

For more:  

 

Category:

Activism, Treatment, Viruses

Comments Off on Bill Gates’ U Washington Lackies Publish New Paper Claiming HCQ Doesn’t Work. Let Me Count the Ways They Have Fixed The Result